Polyrizon Ltd. (NASDAQ:PLRZ) Short Interest Update

Polyrizon Ltd. (NASDAQ:PLRZ) saw a significant drop in short interest during the month of December. As of December 31st, there was short interest totaling 129,601 shares, a drop of 26.4% from the December 15th total of 176,028 shares. Currently, 12.4% of the shares of the company are sold short. Based on an average trading volume of 90,970 shares, the days-to-cover ratio is currently 1.4 days. Based on an average trading volume of 90,970 shares, the days-to-cover ratio is currently 1.4 days. Currently, 12.4% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Wall Street Zen upgraded Polyrizon from a “strong sell” rating to a “hold” rating in a research note on Saturday, September 20th. Weiss Ratings restated a “sell (e+)” rating on shares of Polyrizon in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Polyrizon has an average rating of “Sell”.

Polyrizon Stock Up 0.1%

Shares of NASDAQ PLRZ traded up $0.01 during trading on Friday, reaching $15.55. 50,023 shares of the stock traded hands, compared to its average volume of 154,303. Polyrizon has a 52-week low of $2.88 and a 52-week high of $2,550.00. The company has a 50-day moving average of $8.81 and a 200-day moving average of $7.23.

Polyrizon Company Profile

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.